Infectious Diseases & Vaccines: mRNA Platform Expansion & Antibiotic Resistance
Description
Antibiotics market growing from $55.6B to $67.88B (2030). mRNA platform broadening beyond COVID/flu. Multi-drug resistant bacteria new targets. Rapid vaccine development timelines. Antibiotic stewardship program integration.
Table of Contents
72 Pages
- EXECUTIVE SUMMARY
- 1.1 Infectious Disease Market
- 1.2 Antibiotics & Resistance
- 2.0 mRNA PLATFORM EXPANSION
- 2.1 Vaccine Applications
- 2.2 Therapeutic Opportunities
- 2.3 Manufacturing Optimization
- 3.0 ANTIBIOTIC RESISTANCE
- 3.1 Novel Mechanisms
- 3.2 Difficult-to-Treat Pathogens
- 3.3 Combination Strategies
- 4.0 STEWARDSHIP PROGRAMS
- 4.1 Antibiotic Stewardship
- 4.2 Rapid Diagnostics
- 4.3 Surveillance Integration
- 5.0 PANDEMIC PREPAREDNESS
- 5.1 Rapid Response Platforms
- 5.2 Manufacturing Capacity
- 5.3 Global Collaboration
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


